Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hague

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Diabetes Care|October 11, 2012
Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatmentHelen L Barrett, Kathryn L Gatford, Candice M Houda, et al.
Diabetes Care|February 9, 2013
Determinants of maternal triglycerides in women with gestational diabetes mellitus in the Metformin in Gestational Diabetes (MiG) studyHelen L Barrett, Marloes Dekker Nitert, Lee Jones, et al.
The Medical Journal of Australia|October 6, 2001
Anticoagulation in pregnancy and the puerperiumW M Hague, R A North, A S Gallus, et al.
Biomaterials|January 16, 2022
Ink-jet 3D printing as a strategy for developing bespoke non-eluting biofilm resistant medical devicesYinfeng He, Jeni Luckett, Belen Begines, et al.
The Journal of Biological Chemistry|July 31, 2020
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
The Journal of Clinical Endocrinology and Metabolism|December 10, 2024
Ethnic Differences in Characteristics of Women Diagnosed with Early Gestational Diabetes: Findings from the TOBOGM StudyLili Yuen, Vincent Wong, Jincy Immanuel, et al.
The Journal of Biological Chemistry|November 14, 2020
Correction: Intermittent enzyme replacement therapy prevents Neu1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
Diabetes Care|February 29, 2024
Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment From 24-28 Weeks' Gestation: A TOBOGM Secondary AnalysisDavid Simmons, Jincy Immanuel, William M Hague, et al.
The Medical Journal of Australia|May 26, 2018
Hyperglycaemia in early pregnancy: the Treatment of Booking Gestational diabetes Mellitus (TOBOGM) study. A randomised controlled trialDavid Simmons, William M Hague, Helena J Teede, et al.
The New England Journal of Medicine|May 5, 2023
Treatment of Gestational Diabetes Mellitus Diagnosed Early in PregnancyDavid Simmons, Jincy Immanuel, William M Hague, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Diabetes Care|October 11, 2012
Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatmentHelen L Barrett, Kathryn L Gatford, Candice M Houda, et al.
Diabetes Care|February 9, 2013
Determinants of maternal triglycerides in women with gestational diabetes mellitus in the Metformin in Gestational Diabetes (MiG) studyHelen L Barrett, Marloes Dekker Nitert, Lee Jones, et al.
The Medical Journal of Australia|October 6, 2001
Anticoagulation in pregnancy and the puerperiumW M Hague, R A North, A S Gallus, et al.
Biomaterials|January 16, 2022
Ink-jet 3D printing as a strategy for developing bespoke non-eluting biofilm resistant medical devicesYinfeng He, Jeni Luckett, Belen Begines, et al.
The Journal of Biological Chemistry|July 31, 2020
Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
The Journal of Clinical Endocrinology and Metabolism|December 10, 2024
Ethnic Differences in Characteristics of Women Diagnosed with Early Gestational Diabetes: Findings from the TOBOGM StudyLili Yuen, Vincent Wong, Jincy Immanuel, et al.
The Journal of Biological Chemistry|November 14, 2020
Correction: Intermittent enzyme replacement therapy prevents Neu1 deficiencyAmanda R Luu, Cara Wong, Vishal Agrawal, et al.
Diabetes Care|February 29, 2024
Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment From 24-28 Weeks' Gestation: A TOBOGM Secondary AnalysisDavid Simmons, Jincy Immanuel, William M Hague, et al.
The Medical Journal of Australia|May 26, 2018
Hyperglycaemia in early pregnancy: the Treatment of Booking Gestational diabetes Mellitus (TOBOGM) study. A randomised controlled trialDavid Simmons, William M Hague, Helena J Teede, et al.
The New England Journal of Medicine|May 5, 2023
Treatment of Gestational Diabetes Mellitus Diagnosed Early in PregnancyDavid Simmons, Jincy Immanuel, William M Hague, et al.
Pageof 15